BIOAI READER GUIDE
How to read weekly AI drug discovery updates: companies, research, and coverage gaps
Build a weekly reading routine, distinguish announcements, papers, and clinical results, and understand this site’s weekly indexing window, denominators, and source coverage.
BioAI Daily · Reader guide · updated and sources checked 2026-10-08
Start with the definition of this week’s index
This week’s index counts from Monday 00:00 Beijing time to page generation and includes only currently public, in-scope source records. Academic records follow this site’s selected-journal and AI-topic rules. Indexing time determines the window; source publication dates are shown separately. Older articles indexed for the first time this week are included. These totals do not count all new industry news this week.
Counts use the public list’s deduplication rules. A source record may belong to multiple topics, so adding topic counts can exceed the total record count. The daily digest freezes a selection of up to 100 records from the preceding 24 hours at 08:00 each day. It is a different view from the live weekly count.
Read the week’s material in three passes
| Reading order | Details to record | Next step |
|---|---|---|
| Company announcements | Partners, scope, conditions, announcement date, and original source. | Check existing nodes in company profiles to avoid treating a repost as a new collaboration. [Isomorphic Labs · 2024-01-07 · Company collaboration announcement] |
| Research and models | Inputs, prediction tasks, data splits, baselines, and evaluation metrics. | Check the paper version and experimental subjects before connecting findings to an industry project. [Nature Methods · 2024 · Single-cell foundation model paper] |
| Clinical evidence and follow-up | Specific candidate drugs or study identifiers, registration status, and public results. | Distinguish entering a study, completing it, and publishing results. Preserve missing information. [US National Library of Medicine · Clinical study registration and results database] |
Record changes and what remains unknown
Our suggestion is to write one sentence each week for every new source-linked node: who disclosed what, on which date; whether the evidence is an announcement, computational evaluation, experiment, or clinical result; and what to check next. No newly indexed records for a company does not mean its R&D has stopped. More records for a topic do not alone establish a technological breakthrough.
Before reading, check the source’s last successful collection and connection status. A website or account that is verified but not enabled for collection should not be counted as ongoing coverage. Repeated collection failures can cause omissions. This site distinguishes source records from reviewed events so readers can return to the original material.
A reusable weekly note
Week window: ____. Companies / topics of interest: ____. New public nodes and sources: ____. Level of supporting evidence: ____. Unknown terms, targets, or results: ____. Source coverage gaps: ____. Specific questions for the next review: ____.
Open sources from this week’s index or subscribe to a topic’s RSS. Return to company profiles for longer-term tracking. A weekly note preserves the basis for conclusions and questions to verify; it does not need to turn every indexed record into a news story.
Original sources
- Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations
Isomorphic Labs · 2024-01-07 · Company collaboration announcement - scGPT: toward building a foundation model for single-cell multi-omics using generative AI
Nature Methods · 2024 · Single-cell foundation model paper - ClinicalTrials.gov: clinical research studies and results
US National Library of Medicine · Clinical study registration and results database